BEGIN:VCALENDAR PRODID:-//Microsoft Corporation//Outlook 16.0 MIMEDIR//EN VERSION:2.0 METHOD:PUBLISH X-MS-OLK-FORCEINSPECTOROPEN:TRUE BEGIN:VTIMEZONE TZID:Eastern Standard Time BEGIN:STANDARD DTSTART:16011104T020000 RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11 TZOFFSETFROM:-0400 TZOFFSETTO:-0500 END:STANDARD BEGIN:DAYLIGHT DTSTART:16010311T020000 RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3 TZOFFSETFROM:-0500 TZOFFSETTO:-0400 END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT CLASS:PUBLIC CREATED:20200819T174009Z DESCRIPTION:Unprecedented Year… Discuss at Virtual Tri-Con!\nOver the pas t 27 years\, Molecular Medicine Tri-Conference has served as the leading i nternational meeting place for the precision medicine community. As we fac e the unprecedented task of fighting this pandemic and working together wh ile maintaining social distancing\, Cambridge Healthech Institute once aga in takes the leadership role of bringing together the life science communi ty at the Virtual Conference & Expo 2021. Join over 3\,000 international t hought leaders to discuss the latest research and technologies in COVID-19 diagnostics and vaccines\, point-of-care diagnostics\, biomarkers and liq uid biopsy\, data analytics and artificial intelligence\, and immuno-oncol ogy and cell therapy. In addition to the leading research and technology p resentations you have come to expect at the Tri-Con\, we have added struct ured networking opportunities and the free technology Expo\, for a compreh ensive 3-day program designed to maximize collaboration and innovation… all without leaving your computer.\n\nVirtual Conference Programs - Regist er Early for Maximum Savings!\n\n COVID-19 Diagnostics\n \nImmuno-Oncology Biomarkers \n \n COVID-19 Vaccines & Biotherapeutics\ n Circulating Tum or Cells and Liquid Biopsy\n Point-of-Care Diagnostics\n Data\, Analytics & AI for Precision Medicine\n Clinical & Translational Biomarkers\n Immuno-Oncology and Cell Th erapy\n \nLearn more at www.TriConference.com\n DTEND;TZID="Eastern Standard Time":20210218T170000 DTSTAMP:20200819T174010Z DTSTART;TZID="Eastern Standard Time":20210216T080000 LAST-MODIFIED:20200819T174009Z PRIORITY:5 SEQUENCE:0 SUMMARY;LANGUAGE=en-us:Molecular Med TRI-CON: Virtual Conference & Expo TRANSP:OPAQUE UID:040000008200E00074C5B7101A82E0080000000070381C412E76D601000000000000000 0100000009FE1F544355DF04CB3BA0E06BF3AC922 X-ALT-DESC;FMTTYPE=text/html:\n\nClean\nfalse\n\n\n\n\nfalse\nfalse\nfalse\n\nEN-US\n< w:LidThemeAsian>X-NONE\nX-NONE< /w:LidThemeComplexScript>\n\n\n\n\n\n\n\n\ n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n\n\n\n\n\n\n\n\n

Unprecedented Year…\; Discuss at Virtu al Tri-Con!

Over t he past 27 years\, Molecular Medicine Tri-Conference has served as the lea ding international meeting place for the precision medicine community. As we face the unprecedented task of fighting this pandemic and working toget her while maintaining social distancing\, Cambridge Hea lthech Institute once again takes the leadership role of bringing t ogether the life science community at the Virtual Conference &\; Expo 2 021. Join over 3\,000 international thought leaders to discuss the latest research and technologies in COVID-19 diagnostics and vaccines\, point-of- care diagnostics\, biomarkers and liquid biopsy\, data analytics and artif icial intelligence\, and immuno-oncology and cell therapy. In addition to the leading research and technology presentations you have come to expect at the Tri-Con\, we have added structured networking opportunities and the free technology Expo\, for a comprehensive 3-day program designed to maxi mize collaboration and innovation…\; all without leaving your compute r.

Virtual Conference Programs - \;Register \;Ea rly for Maximum Savings!

 \;

Learn more at www.TriConference.com

X-MICROSOFT-CDO-BUSYSTATUS:BUSY X-MICROSOFT-CDO-IMPORTANCE:1 X-MICROSOFT-DISALLOW-COUNTER:FALSE X-MS-OLK-CONFTYPE:0 BEGIN:VALARM TRIGGER:-PT15M ACTION:DISPLAY DESCRIPTION:Reminder END:VALARM END:VEVENT END:VCALENDAR

COVID-19 Diagnostics

Immuno-Oncology Biomarkers

 \;

COVID-19 Vaccines &\; Biotherapeutics

Circulating Tumor Cells and Liquid Biopsy

Point-of-Care Dia gnostics

Data\, Analytics &\; AI for Precision Medicine

Clinical &\; Translational Biomarkers< o:p>

Immuno-Oncology and Cell Therapy